Labcorp Holdings (LH) Receivables (2009 - 2026)

Labcorp Holdings has reported Receivables for 18 years, with the latest figure at $2.5 billion in Q1 2026.

• Quarterly Receivables rose 7.74% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 7.74% YoY) and the FY2025 annual result came in at $2.3 billion, up 7.81% from the prior year.
• Receivables advanced to $2.5 billion in Q1 2026 per LH's latest filing, from $2.3 billion in the prior quarter.
• Over five years, Receivables peaked at $3.0 billion in Q1 2023 and troughed at $434.1 million in Q4 2022.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2025 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2023: Receivables plunged 70.01% in 2022, then jumped 383.46% in 2023.
• Over 5 years, Receivables stood at $434.1 million in 2022, then soared by 383.46% to $2.1 billion in 2023, then slipped by 0.08% to $2.1 billion in 2024, then gained by 7.81% to $2.3 billion in 2025, then rose by 8.4% to $2.5 billion in 2026.
• According to Business Quant data, Receivables over the past three periods registered $2.5 billion, $2.3 billion, and $2.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.